PMC:7594251 / 93139-94296 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T6","span":{"begin":1005,"end":1012},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"},{"id":"T7","span":{"begin":1067,"end":1074},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":"A second method that can be used to map pharmacophores is called inter-ligand nuclear Overhauser effect (ILOE). This 2D NMR experiment detects when two ligands bind simultaneously to adjacent sites on a protein surface although both of the ligands do not have to bind to the same binding pocket (opposite to INPHARMA, see above) [5,393]. A negative ligand−ligand NOE signal will be created when ligands bind in close proximity to each other whereas ligands that do not bind will show no NOEs, or at most very weak positive ones [372,394]. ILOE also enables determination of the ligand orientations with respect to one another [393]. As in the case of INPHARMA, ILOE can be utilized even in the absence of a 3D protein structure and used with large proteins. Additionally, ILOE differs from INPHARMA in mixing times—for ILOE the mixing times are typically in the range of 600–800 ms [345]. Application of ILOE was first shown on glycolate+NAD+ in the presence of porcine heart lactatedehydrogenase, and by glucose-6-phosphate+NADPH in the presence of L. mesenteroides glucose-6-phosphatedehydrogenase and from that time it has been widely used [393,395,396]."}

LitCovid-PD-FMA-UBERON

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T190","span":{"begin":36,"end":39},"obj":"Body_part"},{"id":"T191","span":{"begin":203,"end":210},"obj":"Body_part"},{"id":"T192","span":{"begin":710,"end":717},"obj":"Body_part"},{"id":"T193","span":{"begin":748,"end":756},"obj":"Body_part"},{"id":"T194","span":{"begin":970,"end":975},"obj":"Body_part"},{"id":"T195","span":{"begin":1005,"end":1012},"obj":"Body_part"},{"id":"T196","span":{"begin":1067,"end":1074},"obj":"Body_part"}],"attributes":[{"id":"A190","pred":"fma_id","subj":"T190","obj":"http://purl.org/sig/ont/fma/fma67847"},{"id":"A191","pred":"fma_id","subj":"T191","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A192","pred":"fma_id","subj":"T192","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A193","pred":"fma_id","subj":"T193","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A194","pred":"fma_id","subj":"T194","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A195","pred":"fma_id","subj":"T195","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A196","pred":"fma_id","subj":"T196","obj":"http://purl.org/sig/ont/fma/fma82743"}],"text":"A second method that can be used to map pharmacophores is called inter-ligand nuclear Overhauser effect (ILOE). This 2D NMR experiment detects when two ligands bind simultaneously to adjacent sites on a protein surface although both of the ligands do not have to bind to the same binding pocket (opposite to INPHARMA, see above) [5,393]. A negative ligand−ligand NOE signal will be created when ligands bind in close proximity to each other whereas ligands that do not bind will show no NOEs, or at most very weak positive ones [372,394]. ILOE also enables determination of the ligand orientations with respect to one another [393]. As in the case of INPHARMA, ILOE can be utilized even in the absence of a 3D protein structure and used with large proteins. Additionally, ILOE differs from INPHARMA in mixing times—for ILOE the mixing times are typically in the range of 600–800 ms [345]. Application of ILOE was first shown on glycolate+NAD+ in the presence of porcine heart lactatedehydrogenase, and by glucose-6-phosphate+NADPH in the presence of L. mesenteroides glucose-6-phosphatedehydrogenase and from that time it has been widely used [393,395,396]."}

LitCovid-PD-UBERON

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T34","span":{"begin":970,"end":975},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"A second method that can be used to map pharmacophores is called inter-ligand nuclear Overhauser effect (ILOE). This 2D NMR experiment detects when two ligands bind simultaneously to adjacent sites on a protein surface although both of the ligands do not have to bind to the same binding pocket (opposite to INPHARMA, see above) [5,393]. A negative ligand−ligand NOE signal will be created when ligands bind in close proximity to each other whereas ligands that do not bind will show no NOEs, or at most very weak positive ones [372,394]. ILOE also enables determination of the ligand orientations with respect to one another [393]. As in the case of INPHARMA, ILOE can be utilized even in the absence of a 3D protein structure and used with large proteins. Additionally, ILOE differs from INPHARMA in mixing times—for ILOE the mixing times are typically in the range of 600–800 ms [345]. Application of ILOE was first shown on glycolate+NAD+ in the presence of porcine heart lactatedehydrogenase, and by glucose-6-phosphate+NADPH in the presence of L. mesenteroides glucose-6-phosphatedehydrogenase and from that time it has been widely used [393,395,396]."}

LitCovid-PD-CLO

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T654","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T655","span":{"begin":201,"end":202},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T656","span":{"begin":338,"end":339},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T657","span":{"begin":367,"end":373},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T658","span":{"begin":705,"end":706},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T659","span":{"begin":879,"end":881},"obj":"http://purl.obolibrary.org/obo/CLO_0007874"},{"id":"T660","span":{"begin":970,"end":975},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T661","span":{"begin":970,"end":975},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T662","span":{"begin":970,"end":975},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T663","span":{"begin":970,"end":975},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T664","span":{"begin":1122,"end":1125},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"A second method that can be used to map pharmacophores is called inter-ligand nuclear Overhauser effect (ILOE). This 2D NMR experiment detects when two ligands bind simultaneously to adjacent sites on a protein surface although both of the ligands do not have to bind to the same binding pocket (opposite to INPHARMA, see above) [5,393]. A negative ligand−ligand NOE signal will be created when ligands bind in close proximity to each other whereas ligands that do not bind will show no NOEs, or at most very weak positive ones [372,394]. ILOE also enables determination of the ligand orientations with respect to one another [393]. As in the case of INPHARMA, ILOE can be utilized even in the absence of a 3D protein structure and used with large proteins. Additionally, ILOE differs from INPHARMA in mixing times—for ILOE the mixing times are typically in the range of 600–800 ms [345]. Application of ILOE was first shown on glycolate+NAD+ in the presence of porcine heart lactatedehydrogenase, and by glucose-6-phosphate+NADPH in the presence of L. mesenteroides glucose-6-phosphatedehydrogenase and from that time it has been widely used [393,395,396]."}

LitCovid-PD-CHEBI

LitCovid-PubTator

{"project":"LitCovid-PubTator","denotations":[{"id":"963","span":{"begin":705,"end":709},"obj":"Gene"},{"id":"964","span":{"begin":1050,"end":1066},"obj":"Species"},{"id":"965","span":{"begin":928,"end":937},"obj":"Chemical"},{"id":"966","span":{"begin":938,"end":942},"obj":"Chemical"},{"id":"967","span":{"begin":1005,"end":1012},"obj":"Chemical"},{"id":"968","span":{"begin":1025,"end":1030},"obj":"Chemical"},{"id":"969","span":{"begin":1067,"end":1074},"obj":"Chemical"}],"attributes":[{"id":"A963","pred":"tao:has_database_id","subj":"963","obj":"Gene:140564"},{"id":"A964","pred":"tao:has_database_id","subj":"964","obj":"Tax:1245"},{"id":"A965","pred":"tao:has_database_id","subj":"965","obj":"MESH:C031149"},{"id":"A966","pred":"tao:has_database_id","subj":"966","obj":"MESH:D009243"},{"id":"A967","pred":"tao:has_database_id","subj":"967","obj":"MESH:D005947"},{"id":"A968","pred":"tao:has_database_id","subj":"968","obj":"MESH:D009249"},{"id":"A969","pred":"tao:has_database_id","subj":"969","obj":"MESH:D005947"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A second method that can be used to map pharmacophores is called inter-ligand nuclear Overhauser effect (ILOE). This 2D NMR experiment detects when two ligands bind simultaneously to adjacent sites on a protein surface although both of the ligands do not have to bind to the same binding pocket (opposite to INPHARMA, see above) [5,393]. A negative ligand−ligand NOE signal will be created when ligands bind in close proximity to each other whereas ligands that do not bind will show no NOEs, or at most very weak positive ones [372,394]. ILOE also enables determination of the ligand orientations with respect to one another [393]. As in the case of INPHARMA, ILOE can be utilized even in the absence of a 3D protein structure and used with large proteins. Additionally, ILOE differs from INPHARMA in mixing times—for ILOE the mixing times are typically in the range of 600–800 ms [345]. Application of ILOE was first shown on glycolate+NAD+ in the presence of porcine heart lactatedehydrogenase, and by glucose-6-phosphate+NADPH in the presence of L. mesenteroides glucose-6-phosphatedehydrogenase and from that time it has been widely used [393,395,396]."}

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T605","span":{"begin":0,"end":111},"obj":"Sentence"},{"id":"T606","span":{"begin":112,"end":337},"obj":"Sentence"},{"id":"T607","span":{"begin":338,"end":538},"obj":"Sentence"},{"id":"T608","span":{"begin":539,"end":632},"obj":"Sentence"},{"id":"T609","span":{"begin":633,"end":757},"obj":"Sentence"},{"id":"T610","span":{"begin":758,"end":888},"obj":"Sentence"},{"id":"T611","span":{"begin":889,"end":1157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A second method that can be used to map pharmacophores is called inter-ligand nuclear Overhauser effect (ILOE). This 2D NMR experiment detects when two ligands bind simultaneously to adjacent sites on a protein surface although both of the ligands do not have to bind to the same binding pocket (opposite to INPHARMA, see above) [5,393]. A negative ligand−ligand NOE signal will be created when ligands bind in close proximity to each other whereas ligands that do not bind will show no NOEs, or at most very weak positive ones [372,394]. ILOE also enables determination of the ligand orientations with respect to one another [393]. As in the case of INPHARMA, ILOE can be utilized even in the absence of a 3D protein structure and used with large proteins. Additionally, ILOE differs from INPHARMA in mixing times—for ILOE the mixing times are typically in the range of 600–800 ms [345]. Application of ILOE was first shown on glycolate+NAD+ in the presence of porcine heart lactatedehydrogenase, and by glucose-6-phosphate+NADPH in the presence of L. mesenteroides glucose-6-phosphatedehydrogenase and from that time it has been widely used [393,395,396]."}